COVID-19 pandemic

The essential role of clinical biochemistry

A wide range of clinical diagnostics play an essential role in the fight against the coronavirus disease 2019 (COVID-19) pandemic.

Although haematology and biochemistry tests cannot diagnose SARS-CoV-2 infection, they are used in several aspects of the COVID-19 care pathway. These include supporting patient management and risk stratification, as well as helping to identify the development of potential complications in diagnosed patients. [1] 

Furthermore, digital solutions that enable remote maintenance of point-of-care testing devices in COVID-19 units can support the work of healthcare professionals and frontline staff. [2]

1. Thompson et al. IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients. Clinical Chemistry and Laboratory Medicine. 2020;58(12):2009-2016.
2. Nair et al. Guidance for use of point of care testing equipment in positive patients and those with a suspected diagnosis of COVID-19 (G204). The Royal College of Pathologists. March 2020.

 

D-dimer and procalcitonin in summary

This summary of two scientific papers suggests that D-dimer and procalcitonin testing may be used to help assess comorbidities in patients hospitalised with COVID-19.

Read more

COVID-19 pandemic — the tide is turning

In this article, Jacob de Haan discusses the emerge of a pandemic, the current understanding of the disease and the virus, how to manage patients diagnosed with COVID-19.

Read more

Laboratory testing is critical

Radiometer Medical General Manager for India & South Asia, Smit Dave, discusses the role of clinical diagnostics during the COVID-19 pandemic.
Read more

The value of D-dimer

In this webinar, Radiometer’s global immunoassay expert, Guillaume Galpy, explains the concept and value of the D-dimer biomarker.
Watch now

Point-of-care testing during the COVID-19 pandemic

Watch as Dr. Nam Tran reviews the effects of COVID-19 on POCT workflows and discusses COVID-19 best practices from the perspective of clinical chemistry.
Watch now

Delivering effective POCT during COVID-19

Listen to Katy Heaney, POCT Speciality Lead, as she discusses the impact of COVID-19 on POCT services and how POCT services will evolve post COVID-19.
Listen now

Speed up patient flow in the ED

Point-of-care testing can help to reduce turnaround times and accelerate patient flow.
Read more

Fast results in the ICU

When ICUs are overrun, you need fast test results at the point-of-care.
Read more

Keep analysers up and running

Remote monitoring and troubleshooting can support analyser uptime.
Read more
MAPSSS-000459 R3

Cookies are used on this website

Use of cookies
Don't show this message again
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
SIGN IN
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

CLOSE BANNER
Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

TRY AGAIN CONTINUE
Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

RESEND E-MAIL
Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

TRY AGAIN
Sorry

It seems this account has not been given access to the portal

Continue

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
    •    
  • Single-sign on experience
    •    
  • Use same credentials to access future services    

Request access

You will receive an invitation to access our services via e-mail when your request  has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.